Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases

61Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

Most chronic liver diseases (CLDs) are characterized by inflammatory processes with aberrant expressions of various pro-and anti-inflammatory mediators in the liver. These mediators are the driving force of many inflammatory liver disorders, which often result in fibrosis, cirrhosis, and liver tumorigenesis. c-Myc is involved in many cellular events such as cell growth, proliferation, and differentiation. c-Myc upregulates IL-8, IL-10, TNF-α, and TGF-β, while IL-1, IL-2, IL-4, TNF-α, and TGF-β promote c-Myc expression. Their interactions play a central role in fibrosis, cirrhosis, and liver cancer. Molecular interference of their interactions offers possible therapeutic potential for CLDs. In this review, current knowledge of the molecular interactions between c-Myc and various well known inflammatory mediators is discussed.

Cite

CITATION STYLE

APA

Liu, T., Zhou, Y., Ko, K. S., & Yang, H. (2015). Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases. Mediators of Inflammation. Hindawi Limited. https://doi.org/10.1155/2015/276850

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free